BioVaxys Technology Corp. (BIOV)
Market Closed
7 Aug, 20:00
CNSX 
CA$
0. 07
0
0%
CA$
1.63M Market Cap
- P/E Ratio
- Div Yield
13,470 Volume
- Eps
CA$ 0.07
Previous Close Want to track BIOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BioVaxys Technology Corp. (BIOV) Statistics
Valuation metrics
Market Cap 1.63M
Enterprise value 2.17M
Trailing P/E (ttm) -0.91
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) -
Price/Book (mrq) -0.56
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.99
Overview
Shares outstanding 29.15M
Float 25.81M
Shares short 380
% Held by insiders 0.08%
% Held by institutions -
Average volume (10 days) 443.02K
Average volume (90 days) 5.32K
Price summary
52-Week low 0.03
52-Week high 0.4
Beta 1.05
50-Day moving average 0.07
200-Day moving average 0.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 11 Sep 2025
Financials
Fiscal year
Fiscal year ends 31 Oct 2024
Most recent quarter (mrq) 30 Apr 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.61%
Return on equity 0.7%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -5.97M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 4.08K
Total cash per share (mrq) 0
Total debt (mrq) 133.72K
Total Debt/Equity (mrq) -0.04
Current ratio (mrq) 0.28%
Book value per share (mrq) -0.12
Cash Flow
Cash flow statement -2.97M
Levered free cash flow (LFCF) -1.03M
